These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17942937)

  • 21. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
    Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
    Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
    Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S; May KF; Tzou KS; Lin T; Bhatt D; Freud AG; Guimond M; Ferketich AK; Liu Y; Caligiuri MA
    Cancer Res; 2004 Nov; 64(21):8062-7. PubMed ID: 15520217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
    J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.
    Gramaglia I; Cooper D; Miner KT; Kwon BS; Croft M
    Eur J Immunol; 2000 Feb; 30(2):392-402. PubMed ID: 10671194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
    Jorritsma A; Bins AD; Schumacher TN; Haanen JB
    Cancer Res; 2008 Apr; 68(7):2455-62. PubMed ID: 18381454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells.
    Kim YH; Seo SK; Choi BK; Kang WJ; Kim CH; Lee SK; Kwon BS
    Cell Immunol; 2005 Dec; 238(2):76-86. PubMed ID: 16524567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells.
    Wall EM; Milne K; Martin ML; Watson PH; Theiss P; Nelson BH
    Cancer Res; 2007 Jul; 67(13):6442-50. PubMed ID: 17616705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.
    Lin GH; Edele F; Mbanwi AN; Wortzman ME; Snell LM; Vidric M; Roth K; Hauser AE; Watts TH
    Eur J Immunol; 2012 Nov; 42(11):2861-74. PubMed ID: 22886791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
    Huang H; Bi XG; Yuan JY; Xu SL; Guo XL; Xiang J
    Gene Ther; 2005 Jun; 12(12):999-1010. PubMed ID: 15789061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
    Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
    Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE; Carrio R; Malek TR
    Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
    Kim TS; Lee BC; Kim E; Cho D; Cohen EP
    Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
    J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
    Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
    Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.